Keros Therapeutics Inc

Insider buying by Keros Therapeutics’ director signals confidence amid volatility, offering investors insight into potential rebound prospects.

Insider sales at Keros Therapeutics are routine “sell‑to‑cover” tax‑withholding moves, not a sign of panic, leaving the company’s biotech prospects intact.